Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific f(ab'γ)2 antibody

Nature Biotechnology

Volumn 17, Issue 2, 1999, Pages 181-186

  Bartlett, Jeffrey S ^a   Kleinschmidt, Jurgen ^b   Boucher, Richard C ^a   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adeno associated virus (AAV); Bispecific antibody; Gene therapy vector; Parvovirus; Targeted transduction

Indexed keywords

BISPECIFIC ANTIBODY; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; INTERNALIZATION; MEGAKARYOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANTIBODIES, BISPECIFIC; CELL LINE; DEPENDOVIRUS; GENE TARGETING; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENO-ASSOCIATED VIRUS; PARVOVIRUS;

EID: 0033007934     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/6185     Document Type: Article

References (45)

1. Samulski, R.J. 1993. Adeno-associated virus: integration at a specific chromosomal locus. Curr. Opin. Genet. Dev. 3:74-80.
2. Xiao, X., Li, J., and Samulski, R.J. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
3. Flotte, T.R., Afione, S.A., and Zeitlin, P.L. 1994. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11:517-521.
4. Kaplitt, M.G., Leone, P., Samulski, R.J., Xiao, X., Pfaff, D.W., O'Malley, K.L. et al. 1994. Long-term expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
5. McCown, T.J., Xiao, X., Li, J., Breese, G.R., and Samulski, R.J. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:99-107.
6. Russell, D.W., Miller, A.D., and Alexander, I.E. 1994. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
7. Flotte, T.R., Afione, S.A., Conrad, C., McGrath, S.A., Solow, R., Oka, H. et al. 1993. Stable in vivo expression of the cystic fibrosis transmembrane regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90:10613-10617.
8. Conrad, C.K., Allen, S.S., Afione, S.A., Reynolds, T.C., Beck, S.E., Fee-Maki, M. et al. 1996. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3:658-668.
9. Miller, J.L., Donahue, R.E., Sellers, S.E., Samulski, R.J., Young, N.S., and Nienhuis, A.W. 1994. Recombinant adeno-associated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91:10183-10187.
10. Walsh, C.E., Nienhuis, A.W., Samulski, R.J., Brown, M.G., Miller, J.L., Young, N.S. et al. 1994. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest. 94:1440-1448.
11. Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P. C., Matelis, L.A. et al. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
12. Kumar, S. and Leffak, M, 1991. Conserved chromatin structure in c-myc 5 flanking DNA after viral transduction. J. Mol. Biol. 222:45-57.
13. Walsh, C.E., Liu, J.M., Xiao, X., Young, N.S., Nienhuis, A.W., and Samulski, R.J. 1992. Regulated high level expression of a human γ-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 89:7257-7261.
14. Chu, T.H., Martinez, I., Sheay, W.C., and Dornburg, R. 1994. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther. 1:292-299.
15. Kasahara, N., Dozy, A.M., and Kan, Y.W. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373-1376.
16. Russell, S.J., Hawkins, R.E., and Winter, G. 1993. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21:1081-1085.
17. Somia, N.V., Zoppe, M., and Verma, I.M. 1995. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc. Natl. Acad. Sci. USA 92:7570-7574.
18. Goldman, C.K., Rogers, B.E., Douglas, J.T., Sosnowski, B.A., Ying, W., Siegal, G.P. et al. 1997. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57:1447-1451.
19. Wickham, T.J., Carrion, M.E., and Kovesdi, I. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:750-756.
20. Wickham, T.J., Segal, D.M., Roelvink, P.W., Carrion, M.E., Lizonova, A., Lee, G.M. et al. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831-6838.
21. Bartlett, J.S., Samulski, R.J., and McCown, T.J. 1998. Selective and rapid uptake of adeno-associated virus type-2 (AAV-2) in brain. Hum. Gene Ther. 9:1181-1186.
22. Summerford, C. and Samulski, R.J. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
23. Mizukami, H., Young, N.S., and Brown, K.E. 1996. Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 217:124-130.
24. Ponnazhagan, S., Wang, X.-S., Woody, M.J., Luo, F., Kang, L.Y., Nallari, M. et al. 1996. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol. 77:1111-1122.
25. Wistuba, A., Weger, S., Kern, A., and Kleinschmidt, J.A. 1995. Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins. J. Virol. 69:5311-5319.
26. Ferrari, F.K., Samulski, T., Shenk, T., and Samulski, R.J. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
27. Alexander, I.E., Russell, D.W., and Miller, A.D. 1994. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68:8282-8287.
28. Russell, D.W., Miller, A.D., and Alexander, I.E. 1995. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92:5719-5723.
29. Montgomery, R.R., Kunicki, T.J., Taves, C., Corcoran, M., and Pidard, D.J. 1983. Diagnosis of Bernard-Soulier syndrome and Glanzmann thrombasthenia with a monoclonal assay of whole blood. J. Clin. Invest. 71:385-389.
30. Pidard, D., Montgomery, R.R., Bennett, J.S., and Kunicki, T.J. 1983. Interaction of AP-2, a monoclonal antibody specific for human platelet glycoprotein IIb-IIIa complex, with intact platelets. J. Biol. Chem. 258:12582-12586.
31. 3 (glycoprotein IIb-IIIa). Blood 82:135-138.
32. Halbert, C.L., Alexander, I.A., Wolgamot, G.M., and Miller, A.D. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortilized cells. J. Virol. 69:1473-1479.
33. Ponnazhagan, S., Wang, X.S., Kang, L.Y., Woody, M.J., Nallari, M.L., Munshi, N.C. et al. 1994. Transduction of human hematopoietic cells by the adeno-associated virus 2 vectors is receptor-mediated. Blood 84:742a.
34. Malik, P., McQuiston, S.A., Yu, X.-J., Pepper, K.A., Krall, W.J., Podsakoff, G.M. et al. 1997. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71:1776-1783.
35. Teramoto, S., Bartlett, J.S., McCarty, D., Xiao, X., Samulski, R.J., and Boucher, R.C. 1998. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: a comparison with adenovirus vectors. J. Virol. 44:8904-8912.
36. Imai, K., Hareyama, M., Makiguchi, Y., Matsumoto, H., and Hinoda, Y. 1997. Monoclonal antibody-conjugated immunotherapy of cancer. Int. Rev. Immunol. 14:213-227.
37. Bodey, B., Siegel, S.E., and Kaiser, H.E. 1996. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Anticancer Res. 16:661-674.
38. Jones, N. and Shenk, T. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17:683-689.
39. Goodman, S., Xiao, X., Donahue, R.E., Moulton, A., Miller, J., Walsh, C. et al. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
40. Samulski, R.J., Srivastava, A., Berns, K.I., and Muzyczka, N. 1983. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33:135-143.
41. Samulski, R.J., Chang, L.-S., and Shenk, T. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.
42. Bartlett, J.S., Xiao, X., and Samulski, R.J. 1996. Adeno-associated virus vectors for gene transfer, pp. 115-127, in Protocols for gene transfer in neuroscience: towards gene therapy of neurological disorders, Lowenstein, P.R. and Enquist, L.W. (eds.). John Wiley & Sons, Chichester, UK.
43. Samulski, R.J., Chang, L.-S., and Shenk, T. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
44. Sanes, J.R., Rubenstein, J.L.R., and Nicolas, J.F. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
45. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cells. J. Mol. Biol. 26:365-369.